Influence of thyroid status on serum immunoreactive leptin levels

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1632-1634

  Valcavi, R ^a   Zini, M ^a   Peino, R ^b   Casanueva, F F ^b   Dieguez, C ^b,c  

^a Hospital S Maria Nuova   (Italy)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; THIAMAZOLE; THYROXINE;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENERGY EXPENDITURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

EID: 0030994935     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1632     Document Type: Article

References (14)

1. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-549.
2. Considine RV, Considine EL, Williams CJ, et al. 1995 Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity J Clin Invest. 95:2986-2988.
3. Sinha MK, Ohannesian JP, Heiman ML, et al. 1996 Nocturnal rise of leptin in lean, obese and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 97:1344-1347.
4. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma proteins encoded by the obese gene. Science. 269:543-546.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 (Erratum in Nature 374:479, 1995).
6. Hamilton BS, Paglia D, Kwan AYM, Deitel M. 1995 Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1:953-956.
7. Lönnqvist F, Amer P, Nordfors L, Schalling M. 1995 Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1:950-953.
8. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292-295.
9. Ferron F, Considine RV, Peino R, Lado IG, Dieguez C, Casanueva FF. 1997 Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa, and unspecific eating disorders are independent of the respective disease but correlate with the body mass index. Clin Endocrinol. In press.
10. Jeanrenaud FR, Jeanrenaud B. 1996 Obesity, leptin and the brain. N Engl J Med. 334:324-325.
11. Meier CA. 1996 Leptin secretion and action: an update. Eur J Endocrinol. 134:543-544.
12. Ingbar SH. 1985 The thyroid gland. In: Wilson JD, Foster DW, eds. Texbook of endocrinology. Philadelphia: Saunders; 975-1170.
13. Leal-Cerro A, Astorga R, Venegas E, Peino R, Casanueva FF, Dieguez C. 1996 Serun inmunoreactive leptin levels are increased in patients with Cushing's syndrome. Horm Metab Res. 28:711-713.
14. Caro JF, Kolaczynski JW, Nyce MR, et al. 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 348:159-161.